rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2000-2-29
|
pubmed:abstractText |
To determine the safety and tolerability of adenovirus-mediated p53 (Adp53) gene transfer in sequence with cisplatin when given by intratumor injection in patients with non-small-cell lung cancer (NSCLC).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0732-183X
|
pubmed:author |
pubmed-author:ConnorsDD,
pubmed-author:DoerksenLL,
pubmed-author:FossellaFF,
pubmed-author:GlissonB SBS,
pubmed-author:HopeW GWG,
pubmed-author:KempB LBL,
pubmed-author:KhuriF RFR,
pubmed-author:KurieJ MJM,
pubmed-author:LawrenceD DDD,
pubmed-author:LeeJ JJJ,
pubmed-author:LeeJ SJS,
pubmed-author:MachHH,
pubmed-author:MerrittJJ,
pubmed-author:NemunaitisJJ,
pubmed-author:NesbittJ CJC,
pubmed-author:NguyenD MDM,
pubmed-author:Perez-SolerRR,
pubmed-author:PistersK MKM,
pubmed-author:PutnamJ BJB,
pubmed-author:RichliW RWR,
pubmed-author:RothJJ,
pubmed-author:ShinD MDM,
pubmed-author:SwisherS GSG,
pubmed-author:TimmonsTT,
pubmed-author:WaitJJ,
pubmed-author:WalshG LGL,
pubmed-author:WeillDD
|
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
609-22
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10653876-Adenoviruses, Human,
pubmed-meshheading:10653876-Adult,
pubmed-meshheading:10653876-Aged,
pubmed-meshheading:10653876-Antibodies, Viral,
pubmed-meshheading:10653876-Antineoplastic Agents,
pubmed-meshheading:10653876-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:10653876-Cisplatin,
pubmed-meshheading:10653876-Combined Modality Therapy,
pubmed-meshheading:10653876-DNA, Neoplasm,
pubmed-meshheading:10653876-DNA Mutational Analysis,
pubmed-meshheading:10653876-Female,
pubmed-meshheading:10653876-Gene Transfer Techniques,
pubmed-meshheading:10653876-Genes, p53,
pubmed-meshheading:10653876-Genetic Vectors,
pubmed-meshheading:10653876-Humans,
pubmed-meshheading:10653876-In Situ Nick-End Labeling,
pubmed-meshheading:10653876-Injections, Intralesional,
pubmed-meshheading:10653876-Lung Neoplasms,
pubmed-meshheading:10653876-Male,
pubmed-meshheading:10653876-Middle Aged,
pubmed-meshheading:10653876-Organ Specificity,
pubmed-meshheading:10653876-Staining and Labeling
|
pubmed:year |
2000
|
pubmed:articleTitle |
Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer.
|
pubmed:affiliation |
US Oncology, Baylor University Medical Center, Dallas, TX, USA. j.nemunaitis@usoncology.com
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase I
|